 Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Jinlan 98+ EP/BP/USP Icotrokinra (JNJ2113)

Jinlan 98+ EP/BP/USP Icotrokinra (JNJ2113)

Name: Jinlan 98+ EP/BP/USP Icotrokinra (JNJ2113)
Brand: Jinlan
SKU: pr2601281141
Price: 852 USD
Availability: InStock

1 Inquiries

Unit Price: Get Latest Price 

CAS No.:

2763602-16-8

Grade:

medical grade

Content:

98%

Port:

Shanghai/Ningbo/Qingdao

Brand:

Jinlan

Packaging:

25kg/Cardboard Drum

Price valid (until):

2026-04-01

Contact Supplier

 Chat Now

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Peptides,API,Intermediate

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

Basic Product Description

CAS Number: 2763602-16-8

Chemical Name: Recombinant fusion protein targeting interleukin-4 receptor alpha (IL-4Rα) and interleukin-13 receptor alpha 1 (IL-13Rα1)

Molecular Formula: Protein-based biologic (amino acid polymer)

Molecular Weight: Approximately 98000 g/mol

Synonyms: JNJ-2113, Icotrokinra recombinant protein

Related Categories: Biologic Therapeutic, Dual IL-4/IL-13 Ligand Trap, Anti-inflammatory Biologic Agent

Key Highlight: A recombinant dual ligand trap biologic that sequesters both IL-4 and IL-13 cytokines, inhibiting their pro-inflammatory signaling cascades. It is investigated for the treatment of type 2 inflammatory diseases such as atopic dermatitis and asthma, delivering targeted anti-inflammatory activity with high cytokine binding affinity.

Basic Info

Product Name:
New peptide drugs CAS 2763602-16-8, Ac-Pen-Asn-Thr-Trp(7-Me)-Lys(Ac)-Pen-Tyr(4-EtNH2)-2-Nal-ThpGly-Glu-Asn-3-Pal-Sar-NH2Bu)-AEEA-AEEA]-OH

CAS No.:
2763602-16-8

Categories:
Other Chemical Drugs
Seller Information

Business Type:
Trader

Main Products:
Peptides,API,Intermediate

Location:
Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1

Payment Terms:
100% TT in advance

Average lead Time:
275

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
51-100

Year of Establishment:
2020

Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd (with its export company Hangzhou Royall Import & Export Co.,Ltd.) is located in Hangzhou, Zhejiang Province. Neighboring Ningbo port, Shanghai port, Hangzhou Xiaoshan Int' l Airport and Shanghai Pudong Int' l Airport, the transportation and production environment are excellent. JINLAN PHARMA mainly business includes: 1) API, Pharmaceutical Intermediates, CMO, CRO, CDMO and so on. 2) Pharmaceutical Equipment such as: Distilled Water Machinery, Mixer, Sterilizer and so on.

JINLAN PHARM focus on:

■ Contrast Agent

■ Anti-COVID APIs

■ Respiratory System APIs

■ Anti-tumor & Anti-Cancer APIs

■ Anti-Diabetes APIs

■ Anti-HCV & Anti-HBV APIs

■ Anti-HIV APIs

■ Peptides

■ Pharmaceutical Intermediates

■ CMO, CRO, CDMO

Inquiry History

1 Inquiries

Country	Product	Purchase Quantity	Date Posted
United States	IL-23 inhibitor peptide	100 PCS	Apr 16, 2026

Post an enquiry for this product

More Choices

Product Name	Grade / Content	Price	Supplier Name	Details
JNJ-2113 is the first oral IL-23 receptor antagonist peptide for moderate-to-severe plaque psoriasis, blocking IL-23 signaling	Pharmaceutical Grade/99		Fujian Genohope Biotech Ltd.	Inquiry

Hot Searches: acetic acid mw; 2-naphthol reacting with naoh formula; nitrous acid formula; formula ammonium phosphate; 2-chlorobenzoic acid; caprylic/capric triglyceride; toluene sds; benzyl acetate; amber acid; cl2o7 compound name; 1 butene; density of cyclooctene



Feedback & Suggestions

Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.

Jinlan 98+ EP/BP/USP Icotrokinra (JNJ2113)

Product Description

Seller Information

Inquiry History

Basic Product Description

More Choices